A case series of immune checkpoint inhibitor induced diabetes mellitus (ICI-DM).

e22080Background: Immune checkpoint inhibitors have activity across oncology, with mostly mild and reversible toxicity. ICI-DM has been reported in only 13 (0.2%) patients (pts) in trials, with lit...